Number of the records: 1  

Mitochondrial targets of metformin-Are they physiologically relevant?

  1. 1.
    0510611 - FGÚ 2020 RIV NL eng J - Journal Article
    Pecinová, Alena - Brázdová, Andrea - Drahota, Zdeněk - Houštěk, Josef - Mráček, Tomáš
    Mitochondrial targets of metformin-Are they physiologically relevant?
    Biofactors. Roč. 45, č. 5 (2019), s. 703-711. ISSN 0951-6433. E-ISSN 1872-8081
    R&D Projects: GA ČR(CZ) GA16-12726S; GA MZd(CZ) NV17-28784A
    Institutional support: RVO:67985823
    Keywords : AMPK * metformin * mitochondria * oxidative phosphorylation
    OECD category: Biochemistry and molecular biology
    Impact factor: 4.734, year: 2019
    Method of publishing: Limited access
    https://doi.org/10.1002/biof.1548

    Metformin is the most widely prescribed treatment of hyperglycemia and type II diabetes since 1970s. During the last 15 years, its popularity increased due to epidemiological evidence, that metformin administration reduces incidence of cancer. However, despite the ongoing effort of many researchers, the molecular mechanisms underlying antihyperglycemic or antineoplastic action of metformin remain elusive. Most frequently, metformin is associated with modulation of mitochondrial metabolism leading to lowering of blood glucose or activation of antitumorigenic pathways. Here we review the reported effects of metformin on mitochondrial metabolism and their potential relevance as effective molecular targets with beneficial therapeutic outcome.
    Permanent Link: http://hdl.handle.net/11104/0301039

     
     
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.